Standardizing care for agitation in Alzheimer's disease, results from a randomized controlled trial of an integrated care pathway versus usual care - the S
Adherence to treatment guidelines for agitation in dementia is suboptimal and inconsistent. We designed and evaluated an Integrated Care Pathway (ICP) for the management of agitation in dementia. This was a double-blind randomized controlled trial at 12 inpatient units and long-t
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.